A PRISMA-driven systematic review for predictive risk factors of digital ulcers in systemic sclerosis patients

被引:48
|
作者
Silva, I. [1 ]
Almeida, J. [2 ]
Vasconcelos, C. [3 ,4 ]
机构
[1] Hosp Santo Antonio, Clin Imunol Unit, Ctr Hosp Porto, P-4150789 Oporto, Portugal
[2] Ctr Hosp Vila Nova de Gaia, Internal Med Serv, Vila Nova De Gaia, Portugal
[3] Hosp Santo Antonio, Ctr Hosp Porto, Clin Imunol Unit, P-4150789 Oporto, Portugal
[4] Univ Porto, UMIB, ICBAS, P-4100 Oporto, Portugal
关键词
Digital ulcer/s; Systemic sclerosis; Autoantibodies; Endothelin-1; Vascular endothelial growth factor (VEGF); C.apillaroscopy; ENDOTHELIAL GROWTH-FACTOR; ANTIENDOTHELIAL CELL ANTIBODIES; SEVERE ORGAN INVOLVEMENT; VON-WILLEBRAND-FACTOR; NAILFOLD CAPILLAROSCOPY; CLINICAL-FEATURES; SCLERODERMA PATIENTS; RAYNAUDS-PHENOMENON; VASCULAR-DISEASE; I ANTIBODIES;
D O I
10.1016/j.autrev.2014.10.009
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Vasculopathy has a major role in the pathogenesis and tissue injury in systemic sclerosis (SSc). Raynaud's phenomenon (RP) is frequently the first clinical manifestation of SSc preceding by years other clinical manifestations. RP in SSc patients is frequent, often very severe and long lasting. The repeated bouts of RP lead to prolonged digital ischemia that may progress to digital ulceration or in extreme to critical digital ischemia with gangrene. Digital ulcers (DU) are a true burden for all patients. They are very painful, with a long and slow healing course, have high risk of infection and are extremely disabling. In adults, up to 40-50% of patients will experience at least one DU in the course of the disease and of these 31-71% will have recurrent ulcers. In order to try to identify predictive risk factors for DU in SSc patients, an extensive literature review was conducted, according to the guidelines proposed at the PRISMA statement. MEDLINE database (PubMed) and Thomson Reuters Web of Knowledge platform were searched for articles published in peer-reviewed journals since 1990 with the last search run on June 2014 and published in English language. The keyword search terms included: digital ulcer/s, systemic sclerosis, scleroderma, digital scars, ischemic complications, autoantibodies, biomarkers, endothelium dysfunction, endothelin-1, vascular endothelial growth factor (VEGF), endostatin, ADMA, endoglin, angiostatin, and capillaroscopy. The following criteria were included: (1) cohorts of SSc patients including patients with DU, (2) endothelium dysfunction and angiogenesis biomarkers compared with a healthy control group, (3) autoantibodies, capillary morphology and distribution, endothelium dysfunction and angiogenesis biomarkers compared between patients with and without digital ulcers, (4) detailed description of the statistical methods used to conclude for predictive factors, and (5) English language. Our search provided a total of 376 citations. Of these, 297 studies were discarded for not meeting the criteria proposed. (C) 2014 Elsevier B.V. All rights reserved.
引用
收藏
页码:140 / 152
页数:13
相关论文
共 50 条
  • [21] Management of digital ulcers in patients with systemic sclerosis
    Riemekasten, G.
    Hoffmann, U.
    Sunderkoetter, C.
    Weiss, N.
    Kuhn, A.
    DEUTSCHE MEDIZINISCHE WOCHENSCHRIFT, 2012, 137 (1-2) : 34 - 40
  • [22] Bosentan for digital ulcers in patients with systemic sclerosis
    Nagai, Yayoi
    Hasegawa, Michiko
    Tago, Osamu
    Ishikawa, Osamu
    JOURNAL OF DERMATOLOGY, 2010, 37 : 68 - 68
  • [23] A score of risk factors associated with ischemic digital ulcers in patients affected by systemic sclerosis treated with iloprost
    Caramaschi, Paola
    Martinelli, Nicola
    Volpe, Alessandro
    Pieropan, Sara
    Tinazzi, Ilaria
    Patuzzo, Giuseppe
    Mahamid, Helal
    Bambara, Lisa Maria
    Biasi, Domenico
    CLINICAL RHEUMATOLOGY, 2009, 28 (07) : 807 - 813
  • [24] A score of risk factors associated with ischemic digital ulcers in patients affected by systemic sclerosis treated with iloprost
    Paola Caramaschi
    Nicola Martinelli
    Alessandro Volpe
    Sara Pieropan
    Ilaria Tinazzi
    Giuseppe Patuzzo
    Helal Mahamid
    Lisa Maria Bambara
    Domenico Biasi
    Clinical Rheumatology, 2009, 28 : 807 - 813
  • [25] Increased risk of mortality in systemic sclerosis-associated digital ulcers: a systematic review and meta-analysis
    Meunier, P.
    Dequidt, L.
    Barnetche, T.
    Lazaro, E.
    Duffau, P.
    Richez, C.
    Couzi, L.
    Truchetet, M. -E.
    Seneschal, J.
    JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY, 2019, 33 (02) : 405 - 409
  • [26] Maresin1 is a predictive marker of new digital ulcers in systemic sclerosis patients
    Pellicano, Chiara
    Romaggioli, Laura
    Miglionico, Marzia
    Colalillo, Amalia
    Ramaccini, Cesarina
    Gigante, Antonietta
    Muscaritoli, Maurizio
    Rosato, Edoardo
    MICROVASCULAR RESEARCH, 2022, 142
  • [27] Ultrasonographic imaging of systemic sclerosis digital ulcers: A systematic literature review and validation steps
    Suliman, Yossra A.
    Bruni, Cosimo
    Hughes, Michael
    Matucci-Cerinic, Marco
    Furst, Daniel E.
    SEMINARS IN ARTHRITIS AND RHEUMATISM, 2021, 51 (02) : 425 - 429
  • [28] Electroencephalographic signatures of the binge drinking pattern during adolescence and young adulthood: A PRISMA-driven systematic review
    Almeida-Antunes, Natalia
    Crego, Alberto
    Carbia, Carina
    Sousa, Sonia S.
    Rodrigues, Rui
    Sampaio, Adriana
    Lopez-Caneda, Eduardo
    NEUROIMAGE-CLINICAL, 2021, 29
  • [29] Prevention of Digital Ulcers in Systemic Sclerosis Patients: A Proposal of Risk Chart.
    Manfredi, Andreina
    Sebastiani, Marco
    D'Amico, Roberto
    Carraro, Valeria
    Bocci, Mario
    Moscatelli, Sheila
    Iudici, Michele
    Colaci, Michele
    Giuggioli, Dilia
    Ferri, Clodoveo
    ARTHRITIS AND RHEUMATISM, 2011, 63 (10): : S568 - S569
  • [30] Risk factors for the development of systemic sclerosis: a systematic review of the literature
    Abbot, Samuel
    Bossingham, David
    Proudman, Susanna
    de Costa, Caroline
    Ho-Huynh, Albert
    RHEUMATOLOGY ADVANCES IN PRACTICE, 2018, 2 (02) : 1 - 12